Month: March 2023
PLANO, Texas, March 30, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 27, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call.
Conference call details:Date: Thursday, April 27, 2023
Time: 8 a.m. CT / 9 a.m. ET
Domestic dial-in number: (888) 330-3567
International dial-in number: (646) 960-0842
Conference ID: 9252310
Webcast Registration: ITGR Q1 2023 Earnings CallAn audio replay will be available for 7 days and can be accessed by dialing (800) 770-2030 or (647) 362-9199 and using Conference...
Uponor Infra sells its district energy business to ISOPLUS
Written by Customer Service on . Posted in Public Companies.
Uponor Corporation, Investor News, 30 March 2023 at 15:00 EEST
Uponor Infra sells its district energy business to ISOPLUS
Uponor Corporation’s subsidiary, Uponor Infra Oy has today entered into an agreement to sell its district energy business to ISOPLUS Suomi Oy, part of ISOPLUS Group, a leading manufacturer of district heating pipes in Europe. The sale agreement includes Uponor’s district energy businesses in Finland, Sweden, Estonia, and Norway as well as its district energy production located in Vaasa, Finland. The district energy business had a net sales level of approximately €40 million in 2022. The transaction will be completed on 31 March 2023. The value of the transaction is not disclosed.
“The divestment is in line with Uponor Infra’s strategy that focuses on growing its core business. While district energy is an attractive...
Bufab Group: Bufab publishes Annual- and Sustainability Report for 2022
Written by Customer Service on . Posted in Public Companies.
PRESSRELEASE, Värnamo 30 Mars 2023Bufab’s Annual- and Sustainability Report for 2022 is now available on the Group’s website www.bufabgroup.com.
The financial year covers the period from 1 January to 31 December 2022.For further information, please contact:
Marcus Söderberg, CFO, Bufab Group, telephone: +46 370 69 69 60This information is information that Bufab AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.00 CET on March 30, 2023.About BufabBufab AB (publ), Corporate Registration Number 556685-6240, is a trading company that offers its customers a full-service solution as Supply Chain Partner for sourcing, quality control and logistics for C-Parts (screws, nuts, etc.). Bufab’s Global Parts...
NAACP and TransUnion Unite to Provide Credit Education For All Stages of Life
Written by Customer Service on . Posted in Public Companies.
BALTIMORE & CHICAGO, March 30, 2023 (GLOBE NEWSWIRE) — The NAACP and TransUnion (NYSE: TRU) announced today the launch of Connecting to Our Financial Future, a credit education website designed to promote financial inclusion among traditionally underserved and underrepresented communities. The announcement comes at a time when more than 45 million consumers in the U.S. are considered to be either credit unserved or underserved, meaning they have little to no credit products.
Traditionally, members of the Black community and other historically marginalized communities have faced more challenges building credit histories and accessing loans at reasonable rates. The website, crafted specifically for these audiences, is designed to reach people where they are in their credit journey — whether just getting started, maintaining...
Sono-Tek Announces First Production Scale System Order Exceeding $600K From Specialty Clean Energy Customer, First Part of Expected Multi-System Program
Written by Customer Service on . Posted in Public Companies.
Order Expected to be Shipped in Current Fiscal Year
MILTON, NY, March 30, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a new order exceeding $0.6 million from a customer in the clean energy sector, the first part of an expected multi-phase program for additional systems.
The clean energy customer initially purchased an R&D system from Sono-Tek for development and progressed to this order for a production scale system. Sono-Tek’s system applies a proprietary thin film on the customer’s product that is used in the green energy market. The order is scheduled to ship during Sono-Tek’s current fiscal year ending February 2024. Future orders from this customer are expected after the successful...
IMUNON Reports 2022 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Public Companies.
Conference Call Begins Today at 11:00 a.m. Eastern Time
LAWRENCEVILLE, N.J., March 30, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation vaccines, today announced financial results for the year ended December 31, 2022, and provided an update on its clinical development programs with IMNN-001 (formerly GEN-1), a DNA-based interleukin-12 (IL-12) immunotherapy in Phase 2 clinical development for the treatment of advanced-stage ovarian cancer, and with PLACCINE, a proprietary, multivalent DNA plasmid technology utilizing synthetic, non-viral vaccine delivery vectors being evaluated in preclinical studies for superiority over current generation of nucleic acid vaccines.
Highlights of 2022 and recent weeks include:Completed...
Galectin Therapeutics Reports 2022 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Public Companies.
NORCROSS, Ga., March 30, 2023 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2022. These results are included in the Company’s Annual Report on Form 10-K, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov.
Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, said: “As previously reported, we completed recruitment in late December 2022 and randomization by the end of February 2023 in our adaptively designed Phase 2b/3 NAVIGATE trial for the prevention of esophageal varices in patients with NASH cirrhosis with a total of 357 patients. We randomized more patients than we had...
Achieve Life Sciences Announces Refresh to Board of Directors
Written by Customer Service on . Posted in Public Companies.
SEATTLE, Wash. and VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced changes to the Company’s Board of Directors to continue to support the future direction of the Company.
As provided in the previously reported Cooperation Agreement, as amended, between the Company and certain of its shareholders, Mr. Stuart Duty, Mr. Thomas King, and Mr. Tom Sellig have been appointed to the Board of Directors and will be nominated for election at the Company’s Annual Meeting of Stockholders to be held in June 2023. Additionally, each of Mr. Donald Joseph, Dr. Martin Mattingly, and Mr. Jay Moyes will not be nominated...
Theriva Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
Written by Customer Service on . Posted in Public Companies.
– Dosed the first patient in VIRAGE, a Phase 2b clinical trial of systemically administered VCN-01 in combination with chemotherapy for Pancreatic Ductal Adenocarcinoma –
– Dosed the first patient in the investigator sponsored Phase 1 clinical trial of VCN-01 for patients with brain tumors –
– Presented positive safety and pharmacokinetic data from the ongoing Phase 1b/2a clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant recipients at 2023 Tandem Meetings Transplantation & Cellular Therapy Meetings; Dosed the first patient in Cohort 2 –
– As of December 31, 2022, Theriva Biologics reports $41.8 million in cash, which is expected to provide runway into the third quarter of 2024 –
– Conference call and webcast to be held on Thursday, March 30th at 8:30 a.m. ET –
ROCKVILLE, Md., March 30, 2023 (GLOBE...
H2O Innovation’s O&M Business Line Receives Recognition Awards
Written by Customer Service on . Posted in Public Companies.
QUEBEC CITY, March 30, 2023 (GLOBE NEWSWIRE) — (TSX: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is proud to announce that its Operation and Maintenance (O&M) business line has received two recognition awards, which speak to the team’s continued dedicated service and great performance.
For the third year in a row, the Corporation’s O&M contract with the City of Canton, GA, was honored with the Gold Award by the Georgia Association of Water Professionals (GAWP). This award recognizes exceptional performance in the delivery of safe drinking water and the protection of Georgia’s water resources, as this type of leadership is essential to a prosperous future for all Georgians. “Congratulations to H2O Innovation and all the staff at the water plant for continued outstanding service. This is well deserved,” stated...
